- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 267375, 8 pages
Identification of Lung-Cancer-Related Genes with the Shortest Path Approach in a Protein-Protein Interaction Network
1The Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
2Key Laboratory of Systems Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
3Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
4College of Information Engineering, Shanghai Maritime University, Shanghai 201306, China
5Department of Ophthalmology, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, China
6Department of Biomedical Engineering Tianjin University, Tianjin Key Lab of BME Measurement, Tianjin 300072, China
7CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
8Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
9Institute of Systems Biology, Shanghai University, Shanghai 200444, China
Received 12 March 2013; Revised 19 April 2013; Accepted 29 April 2013
Academic Editor: Bing Niu
Copyright © 2013 Bi-Qing Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics,” A Cancer Journal for Clinicians, vol. 62, pp. 10–29, 2012.
- J. P. van Meerbeeck, D. A. Fennell, and De Ruysscher, “DKM Small-cell lung cancer,” The Lancet, vol. 378, pp. 1741–1755.
- E. Nabieva, K. Jim, A. Agarwal, B. Chazelle, and M. Singh, “Whole-proteome prediction of protein function via graph-theoretic analysis of interaction maps,” Bioinformatics, vol. 21, supplement 1, pp. i302–i310, 2005.
- D. Szklarczyk, A. Franceschini, M. Kuhn et al., “The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored,” Nucleic Acids Research, vol. 39, no. 1, pp. D561–D568, 2011.
- R. Sharan, I. Ulitsky, and R. Shamir, “Network-based prediction of protein function,” Molecular Systems Biology, vol. 3, article 88, 2007.
- P. Bogdanov and A. K. Singh, “Molecular function prediction using neighborhood features,” IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol. 7, no. 2, pp. 208–217, 2010.
- Y. A. Kourmpetis, A. D. van Dijk, M. C. Bink, R. C. van Ham, and C. J. ter Braak, “Bayesian Markov Random Field analysis for protein function prediction based on network data,” PLoS One, vol. 5, article e9293, 2010.
- K. L. Ng, J. S. Ciou, and C. H. Huang, “Prediction of protein functions based on function-function correlation relations,” Computers in Biology and Medicine, vol. 40, no. 3, pp. 300–305, 2010.
- U. Karaoz, T. M. Murali, S. Letovsky et al., “Whole-genome annotation by using evidence integration in functional-linkage networks,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2888–2893, 2004.
- S. Letovsky and S. Kasif, “Predicting protein function from protein/protein interaction data: a probabilistic approach,” Bioinformatics, vol. 19, supplement 1, pp. i197–i204, 2003.
- E. W. Dijkstra, “A note on two problems in connexion with graphs,” Numerische Mathematik, vol. 1, no. 1, pp. 269–271, 1959.
- M. Kanehisa and Subramaniam, “The KEGG database,” Novartis Foundation Symposium, vol. 247, pp. 91–103, 2002.
- S. Kastner, T. Voss, S. Keuerleber, C. Glِckel, M. Freissmuth, and W. Sommergruber, “Expression of G protein-coupled receptor 19 in human lung cancer cells is triggered by entry into S-phase and supports G(2)-m cell-cycle progression,” Molecular Cancer Research, vol. 10, pp. 1343–1358, 2012.
- B. M. Bolstad, R. A. Irizarry, M. Åstrand, and T. P. Speed, “A comparison of normalization methods for high density oligonucleotide array data based on variance and bias,” Bioinformatics, vol. 19, no. 2, pp. 185–193, 2003.
- S. Zhang, “A comprehensive evaluation of SAM, the SAM R-package and a simple modification to improve its performance,” BMC Bioinformatics, vol. 8, article 230, 2007.
- Y. Benjamini and Y. Hochberg, “Controlling the false discovery rate: a practical and powerful approach to multiple testing,” Journal of the Royal Statistical Society Series B, vol. 57, pp. 289–300, 1995.
- S. H. Nagaraj and A. Reverter, “A Boolean-based systems biology approach to predict novel genes associated with cancer: application to colorectal cancer,” BMC Systems Biology, vol. 5, article 35, 2011.
- J. L. Huret, P. Dessen, and A. Bernheim, “Atlas of genetics and cytogenetics in oncology and haematology, year 2003,” Nucleic Acids Research, vol. 31, no. 1, pp. 272–274, 2003.
- T. S. K. Prasad, R. Goel, K. Kandasamy et al., “Human protein reference database—2009 update,” Nucleic Acids Research, vol. 37, no. 1, pp. D767–D772, 2009.
- B. Q. Li, J. Zhang, T. Huang, L. Zhang, and Y. D. Cai, “Identification of retinoblastoma related genes with shortest path in a protein-protein interaction network,” Biochimie, vol. 94, pp. 1910–1917, 2012.
- B. Q. Li, T. Huang, L. Liu, Y. D. Cai, and K. C. Chou, “Identification of colorectal cancer related genes with mRMR and shortest path in protein-protein interaction network,” PLoS One, vol. 7, Article ID e33393, 2012.
- G. Csardi and T. Nepusz, “The igraph software package for complex network research,” InterJournal Complex Systems, 2006.
- D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009.
- Y. Benjamini and D. Yekutieli, “The control of the false discovery rate in multiple testing under dependency,” Annals of Statistics, vol. 29, no. 4, pp. 1165–1188, 2001.
- L. Whitesell and S. L. Lindquist, “HSP90 and the chaperoning of cancer,” Nature Reviews Cancer, vol. 5, no. 10, pp. 761–772, 2005.
- J. Trepel, M. Mollapour, G. Giaccone, and L. Neckers, “Targeting the dynamic HSP90 complex in cancer,” Nature Reviews Cancer, vol. 10, no. 8, pp. 537–549, 2010.
- M. Senju, N. Sueoka, A. Sato et al., “Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines,” Journal of Cancer Research and Clinical Oncology, vol. 132, no. 3, pp. 150–158, 2006.
- J. Frasor, J. M. Danes, B. Komm, K. C. N. Chang, C. Richard Lyttle, and B. S. Katzenellenbogen, “Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype,” Endocrinology, vol. 144, no. 10, pp. 4562–4574, 2003.
- J. C. Lai, Y. W. Cheng, H. L. Chiou, M. F. Wu, C. Y. Chen, and H. Lee, “Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer,” International Journal of Cancer, vol. 117, no. 6, pp. 974–980, 2005.
- Y. Yoshioka, J. Sasaki, M. Yamamoto, et al., “Quantitation by 1H-NMR of dolichol, cholesterol and choline-containing lipids in extracts of normal and phathological thyroid tissue,” NMR in Biomedicine, vol. 13, pp. 377–383, 2000.
- K. Kolanjiappan, C. R. Ramachandran, and S. Manoharan, “Biochemical changes in tumor tissues of oral cancer patients,” Clinical Biochemistry, vol. 36, no. 1, pp. 61–65, 2003.
- B. Smith and H. Land, “Anticancer activity of the cholesterol exporter ABCA1 gene,” Cell Reports, vol. 2, pp. 580–590.
- D. Yee, “Targeting insulin-like growth factor pathways,” British Journal of Cancer, vol. 94, no. 4, pp. 465–468, 2006.
- C. H. Han, J. Y. Cho, J. T. Moon et al., “Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer,” Oncology Reports, vol. 16, no. 6, pp. 1205–1210, 2006.
- A. M. Houghton, D. M. Rzymkiewicz, H. Ji et al., “Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth,” Nature Medicine, vol. 16, no. 2, pp. 219–223, 2010.
- G. Liu and X. Chen, “The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis,” Oncogene, vol. 21, no. 47, pp. 7195–7204, 2002.
- P. M. Hwang, F. Bunz, J. Yu et al., “Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells,” Nature Medicine, vol. 7, no. 11, pp. 1111–1117, 2001.
- A. J. Ridley, M. A. Schwartz, K. Burridge et al., “Cell migration: integrating signals from front to back,” Science, vol. 302, no. 5651, pp. 1704–1709, 2003.
- P. S. Hodkinson, T. Elliott, W. S. Wong et al., “ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase,” Cell Death and Differentiation, vol. 13, no. 10, pp. 1776–1788, 2006.
- Y. P. Choi, B. G. Kim, M. Q. Gao, S. Kang, and N. H. Cho, “Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer,” Biochemical and Biophysical Research Communications, vol. 427, no. 3, pp. 642–648, 2012.
- T. Sethi, R. C. Rintoul, S. M. Moore et al., “Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo,” Nature Medicine, vol. 5, no. 6, pp. 662–668, 1999.
- Y. Tan, P. Raychaudhuri, and R. H. Costa, “Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes,” Molecular and Cellular Biology, vol. 27, no. 3, pp. 1007–1016, 2007.
- Z. Fu, L. Malureanu, J. Huang et al., “Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression,” Nature Cell Biology, vol. 10, no. 9, pp. 1076–1082, 2008.
- R. Y. M. Ma, T. H. K. Tong, A. M. S. Cheung, A. C. C. Tsang, W. Y. Leung, and K. M. Yao, “Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c,” Journal of Cell Science, vol. 118, no. 4, pp. 795–806, 2005.
- R. H. Costa, V. V. Kalinichenko, M. L. Major, and P. Raychaudhuri, “New and unexpected: forkhead meets ARF,” Current Opinion in Genetics and Development, vol. 15, no. 1, pp. 42–48, 2005.
- T. V. Kalin, I. C. Wang, T. J. Ackerson et al., “Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice,” Cancer Research, vol. 66, no. 3, pp. 1712–1720, 2006.
- D. R. Wonsey and M. T. Follettie, “Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe,” Cancer Research, vol. 65, no. 12, pp. 5181–5189, 2005.
- M. T. Teh, S. T. Wong, G. W. Neill, L. R. Ghali, M. P. Philpott, and A. G. Quinn, “FOXM1 is a downstream target of Gli1 in basal cell carcinomas,” Cancer Research, vol. 62, no. 16, pp. 4773–4780, 2002.
- K. Obama, K. Ura, M. Li et al., “Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma,” Hepatology, vol. 41, no. 6, pp. 1339–1348, 2005.
- C. Pilarsky, M. Wenzig, T. Specht, H. D. Saeger, and R. Grützmann, “Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data,” Neoplasia, vol. 6, no. 6, pp. 744–750, 2004.
- I. M. Kim, T. Ackerson, S. Ramakrishna et al., “The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer,” Cancer Research, vol. 66, no. 4, pp. 2153–2161, 2006.
- M. Kong, D. Ditsworth, T. Lindsten, and C. B. Thompson, “α4 is an essential regulator of PP2A phosphatase activity,” Molecular Cell, vol. 36, no. 1, pp. 51–60, 2009.
- V. Janssens and J. Goris, “Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling,” Biochemical Journal, vol. 353, no. 3, pp. 417–439, 2001.
- T. Yorimitsu, C. He, K. Wang, and D. J. Klionsky, “Tap42-associated protein phosphatase type 2A negatively regulates induction of autophagy,” Autophagy, vol. 5, no. 5, pp. 616–624, 2009.
- J. D. Arroyo and W. C. Hahn, “Involvement of PP2A in viral and cellular transformation,” Oncogene, vol. 24, no. 52, pp. 7746–7755, 2005.
- K. Murata, J. Wu, and D. L. Brautigan, “B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 20, pp. 10624–10629, 1997.
- L. P. Chen, Y. D. Lai, D. C. Li et al., “α4 is highly expressed in carcinogen-transformed human cells and primary human cancers,” Oncogene, vol. 30, no. 26, pp. 2943–2953, 2011.
- S. Sakashita, D. Li, N. Nashima et al., “Overexpression of immunoglobulin (CD79a) binding protein1 (IGBP-1) in small lung adenocarcinomas and its clinicopathological significance,” Pathology International, vol. 61, no. 3, pp. 130–137, 2011.
- D. Li, S. Sakashita, Y. Morishita et al., “Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line,” Anticancer Research, vol. 31, no. 2, pp. 529–534, 2011.